Description

Berberine treatment in cats with experimentally induced ulcerative colitis is associated with changes in microbial metabolite profiles. These metabolomic alterations suggest a potential mechanism by which berberine modulates gut inflammation.

Figure 9

Chart

Source Paper

Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.

Microbiology spectrum (2022)

PMID: 36287004

DOI: 10.1128/spectrum.03207-22

Cite This Figure

![Figure 9: Berberine treatment in cats with experimentally induced ulcerative colitis is associated with changes in microbial metabolite profiles. These metabolomic alterations suggest a potential mechanism by which berberine modulates gut inflammation.]()

> Source: Xueying Li et al. "Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerat." *Microbiology spectrum*, 2022. PMID: [36287004](https://pubmed.ncbi.nlm.nih.gov/36287004/)

<figure>
  <img src="" alt="Berberine treatment in cats with experimentally induced ulcerative colitis is associated with changes in microbial metabolite profiles. These metabolomic alterations suggest a potential mechanism by which berberine modulates gut inflammation." />
  <figcaption>Figure 9. Berberine treatment in cats with experimentally induced ulcerative colitis is associated with changes in microbial metabolite profiles. These metabolomic alterations suggest a potential mechanism by which berberine modulates gut inflammation.<br>  Source: Xueying Li et al. "Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerat." <em>Microbiology spectrum</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36287004/">36287004</a></figcaption>
</figure>

Related Evidence

Berberine for Acute Diarrhea

Grade C · 4 studies

Berberine for Gut Dysbiosis

Grade D · 2 studies